Literature DB >> 32875460

Screening for HIV-Associated Neurocognitive Disorder (HAND) in Adults Aged 50 and Over Attending a Government HIV Clinic in Kilimanjaro, Tanzania. Comparison of the International HIV Dementia Scale (IHDS) and IDEA Six Item Dementia Screen.

Johanna Kellett-Wright1, Aidan Flatt1, Patrick Eaton1, Sarah Urasa2, William Howlett2, Marieke Dekker2, Aloyce Kisoli2, Ashanti Duijinmaijer3, Jessica Thornton4, Judith McCartney4, Vanessa Yarwood4, Charley Irwin4, Elizabeta Mukaetova-Ladinska5,6, Rufus Akinyemi7, Bingileki Lwezuala8, William K Gray9, Richard W Walker1,9, Catherine L Dotchin1,9, Philip Makupa8, Stella-Maria Paddick10,11.   

Abstract

Validated screening tools for HIV-associated neurocognitive disorders (HAND) are lacking for the newly emergent ageing population of people living with HIV (PLWH) in sub-Saharan Africa (SSA). We aimed to validate and compare diagnostic accuracy of two cognitive screening tools, the International HIV dementia scale (IHDS), and the Identification and Interventions for Dementia in Elderly Africans (IDEA) screen, for identification of HAND in older PLWH in Tanzania. A systematic sample of 253 PLWH aged ≥ 50 attending a Government clinic in Tanzania were screened with the IHDS and IDEA. HAND were diagnosed by consensus American Academy of Neurology (AAN) criteria based on detailed clinical neuropsychological assessment. Strict blinding was maintained between screening and clinical evaluation. Both tools had limited diagnostic accuracy for HAND (area under the receiver operating characteristic (AUROC) curve 0.639-0.667 IHDS, 0.647-0.713 IDEA), which was highly-prevalent (47.0%). Accurate HAND screening tools for older PLWH in SSA are needed.

Entities:  

Keywords:  Cognitive impairment; HIV; IHDS; Older adults; Screening; Sub-Saharan Africa

Mesh:

Year:  2021        PMID: 32875460      PMCID: PMC7846532          DOI: 10.1007/s10461-020-02998-9

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  56 in total

Review 1.  Neurocognitive dysfunction in the highly active antiretroviral therapy era.

Authors:  Nomvuyo Z Mothobi; Bruce J Brew
Journal:  Curr Opin Infect Dis       Date:  2012-02       Impact factor: 4.915

2.  Vascular cognitive impairment and HIV-associated neurocognitive disorder: a new paradigm.

Authors:  Lucette A Cysique; Bruce J Brew
Journal:  J Neurovirol       Date:  2019-01-11       Impact factor: 2.643

Review 3.  The end of AIDS: HIV infection as a chronic disease.

Authors:  Steven G Deeks; Sharon R Lewin; Diane V Havlir
Journal:  Lancet       Date:  2013-10-23       Impact factor: 79.321

Review 4.  HIV-1 infection and cognitive impairment in the cART era: a review.

Authors:  Judith Schouten; Paola Cinque; Magnus Gisslen; Peter Reiss; Peter Portegies
Journal:  AIDS       Date:  2011-03-13       Impact factor: 4.177

5.  WHO Neuropsychiatric AIDS study, cross-sectional phase II. Neuropsychological and neurological findings.

Authors:  M Maj; P Satz; R Janssen; M Zaudig; F Starace; L D'Elia; B Sughondhabirom; M Mussa; D Naber; D Ndetei
Journal:  Arch Gen Psychiatry       Date:  1994-01

Review 6.  Screening for mild cognitive impairment: a systematic review.

Authors:  Jane A Lonie; Kevin M Tierney; Klaus P Ebmeier
Journal:  Int J Geriatr Psychiatry       Date:  2009-09       Impact factor: 3.485

Review 7.  Evolving clinical phenotypes in HIV-associated neurocognitive disorders.

Authors:  Ned Sacktor; Kevin Robertson
Journal:  Curr Opin HIV AIDS       Date:  2014-11       Impact factor: 4.283

Review 8.  Changing clinical phenotypes of HIV-associated neurocognitive disorders.

Authors:  Ned Sacktor
Journal:  J Neurovirol       Date:  2017-07-27       Impact factor: 3.739

9.  HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors.

Authors:  Robert K Heaton; Donald R Franklin; Ronald J Ellis; J Allen McCutchan; Scott L Letendre; Shannon Leblanc; Stephanie H Corkran; Nichole A Duarte; David B Clifford; Steven P Woods; Ann C Collier; Christina M Marra; Susan Morgello; Monica Rivera Mindt; Michael J Taylor; Thomas D Marcotte; J Hampton Atkinson; Tanya Wolfson; Benjamin B Gelman; Justin C McArthur; David M Simpson; Ian Abramson; Anthony Gamst; Christine Fennema-Notestine; Terry L Jernigan; Joseph Wong; Igor Grant
Journal:  J Neurovirol       Date:  2010-12-21       Impact factor: 2.643

10.  The protocols for the 10/66 dementia research group population-based research programme.

Authors:  Martin Prince; Cleusa P Ferri; Daisy Acosta; Emiliano Albanese; Raul Arizaga; Michael Dewey; Svetlana I Gavrilova; Mariella Guerra; Yueqin Huang; K S Jacob; E S Krishnamoorthy; Paul McKeigue; Juan Llibre Rodriguez; Aquiles Salas; Ana Luisa Sosa; Renata M M Sousa; Robert Stewart; Richard Uwakwe
Journal:  BMC Public Health       Date:  2007-07-20       Impact factor: 3.295

View more
  4 in total

1.  Screening Accuracy of Mini Addenbrooke's Cognitive Examination Test for HIV-Associated Neurocognitive Disorders in People Ageing with HIV.

Authors:  Mattia Trunfio; Davide De Francesco; Daniela Vai; Caterina Medina; Maurizio Milesi; Simone Domini; Chiara Alcantarini; Daniele Imperiale; Stefano Bonora; Giovanni Di Perri; Andrea Calcagno
Journal:  AIDS Behav       Date:  2022-01-04

2.  Mental health and well-being of older adults living with HIV in sub-Saharan Africa: a systematic review.

Authors:  Patrick Nzivo Mwangala; Adam Mabrouk; Ryan Wagner; Charles R J C Newton; Amina A Abubakar
Journal:  BMJ Open       Date:  2021-09-22       Impact factor: 3.006

3.  Evaluation of a low-resource screening strategy for ophthalmic pathologies and associated neurological morbidity in an older Tanzanian HIV-positive population.

Authors:  Grace George; Declan C Murphy; H D Jeffry Hogg; Japhet Bright Boniface; Sarah Urasa; Justus Rwiza; Livin Uwemeye; Clare Bristow; Grace Hillsmith; Emma Rainey; Richard Walker; William K Gray; Stella Maria-Paddick
Journal:  Sci Rep       Date:  2022-01-26       Impact factor: 4.379

4.  Fewer neurocognitive deficits and less brain atrophy by third ventricle measurement in PLWH treated with modern ART: A prospective analysis.

Authors:  Dominic Kaddu-Mulindwa; Matthias Heit; Gudrun Wagenpfeil; Moritz Bewarder; Klaus Fassbender; Stefanie Behnke; Umut Yilmaz; Mathias Fousse
Journal:  Front Neurol       Date:  2022-08-23       Impact factor: 4.086

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.